Skip to main content

Table 3 Reason for ineligibility by recruitment source

From: Effective recruitment of participants to a phase I study using the internet and publicity releases through charities and patient organisations: analysis of the adaptive study of IL-2 dose on regulatory T cells in type 1 diabetes (DILT1D)

Source Age Thyroid disorder Diagnosis Durationa Drug Malignancy <5 yrs Medical history Pregnancy/Breast feeding
Clinics 2 (2.3%) 3 (3.4%) 2 (2.3%) 11 (13%) 0 (0%) 0 (0%) 0 (0%) 2 (2.3%)
Register 1 (1.7%) 2 (3.4%) 1 (1.7%) 2 (3.4%) 1 (1.7%) 0 (0%) 0 (0%) 0 (0%)
Internet 25 (15%) 0 (0%) 0 (0%) 24 (15%) 0 (0%) 1 (0.6%) 1 (0.6%) 1 (0.6%)
  1. a11 participants who registered with the DILT1D study team had a duration of T1D of between 20 and 24 months. This group were unable to enrol in the trial before they became ineligible.